An open label study of the contraceptive efficacy of norethindrone [norethisterone] and ethinyl estradiol

Trial Profile

An open label study of the contraceptive efficacy of norethindrone [norethisterone] and ethinyl estradiol

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2013

At a glance

  • Drugs Ethinylestradiol; Norethisterone
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Sponsors Warner Chilcott
  • Most Recent Events

    • 12 May 2009 Actual patient number (1702) added as reported by ClinicalTrials.gov.
    • 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Jan 2009 Planned end date changed from 1 Aug 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top